Pacira BioSciences (PCRX) Competitors

Perrigo (NYSE:PRGO) and Pacira BioSciences (NASDAQ:PCRX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.

Does the MarketBeat Community believe in PRGO or PCRX?

Pacira BioSciences received 59 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 71.55% of users gave Pacira BioSciences an outperform vote while only 66.35% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Perrigo	Outperform Votes 771 66.35%	Underperform Votes 391 33.65%
Pacira BioSciences	Outperform Votes 830 71.55%	Underperform Votes 330 28.45%

Do institutionals and insiders hold more shares of PRGO or PCRX?

95.9% of Perrigo shares are held by institutional investors. Comparatively, 99.7% of Pacira BioSciences shares are held by institutional investors. 0.7% of Perrigo shares are held by insiders. Comparatively, 6.4% of Pacira BioSciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has preferable earnings and valuation, PRGO or PCRX?

Pacira BioSciences has lower revenue, but higher earnings than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Pacira BioSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perrigo	$4.37B	0.80	-$12.70M	-$1.25	-20.44
Pacira BioSciences	$700.97M	1.78	$41.96M	-$2.19	-12.34

Is PRGO or PCRX more profitable?

Perrigo has a net margin of -3.64% compared to Pacira BioSciences' net margin of -13.07%. Pacira BioSciences' return on equity of 13.42% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perrigo	-3.64%	7.38%	3.18%
Pacira BioSciences	-13.07%	13.42%	7.19%

Which has more risk and volatility, PRGO or PCRX?

Perrigo has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500. Comparatively, Pacira BioSciences has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500.

Do analysts prefer PRGO or PCRX?

Perrigo currently has a consensus price target of $33.00, indicating a potential upside of 29.13%. Pacira BioSciences has a consensus price target of $26.67, indicating a potential downside of 1.31%. Given Perrigo's higher probable upside, research analysts plainly believe Perrigo is more favorable than Pacira BioSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perrigo	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Pacira BioSciences	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33

Does the media refer more to PRGO or PCRX?

In the previous week, Pacira BioSciences had 4 more articles in the media than Perrigo. MarketBeat recorded 17 mentions for Pacira BioSciences and 13 mentions for Perrigo. Perrigo's average media sentiment score of 0.99 beat Pacira BioSciences' score of 0.70 indicating that Perrigo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Perrigo	8 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pacira BioSciences	8 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pacira BioSciences beats Perrigo on 13 of the 18 factors compared between the two stocks.